1. Home
  2. CETX vs CASI Comparison

CETX vs CASI Comparison

Compare CETX & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cemtrex Inc.

CETX

Cemtrex Inc.

HOLD

Current Price

$1.42

Market Cap

17.5M

Sector

Technology

ML Signal

HOLD

Logo CASI Pharmaceuticals Inc.

CASI

CASI Pharmaceuticals Inc.

HOLD

Current Price

$0.82

Market Cap

19.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CETX
CASI
Founded
1998
1991
Country
United States
China
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.5M
19.7M
IPO Year
1998
1996

Fundamental Metrics

Financial Performance
Metric
CETX
CASI
Price
$1.42
$0.82
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
1.0M
26.1K
Earning Date
02-13-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$76,488,088.00
$26,846,000.00
Revenue This Year
$20.41
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
14.39
21.72
52 Week Low
$1.36
$0.74
52 Week High
$42.60
$3.09

Technical Indicators

Market Signals
Indicator
CETX
CASI
Relative Strength Index (RSI) 36.98 38.96
Support Level $1.37 $0.74
Resistance Level $1.60 $0.97
Average True Range (ATR) 0.15 0.09
MACD 0.02 -0.02
Stochastic Oscillator 10.38 19.74

Price Performance

Historical Comparison
CETX
CASI

About CETX Cemtrex Inc.

Cemtrex Inc is a multi-industry technology company. It has expanded into a range of sectors, including smart technologies, virtual and augmented realities, industrial solutions, and intelligent security systems. The company's operating segment includes the Security segment and the Industrial Services segment. The security segment provides end-to-end security to all industrial, corporate, and governmental security via its owned subsidiary, Vicon. Whereas the AIS part Industrial Service Segment is expertise services for rigging, millwrighting, in-plant maintenance, equipment erection, relocation, and disassembly to diversified customers. It generates maximum revenue from the Industrial Service Segment, and from the USA. It also operates UK, USA, and Other.

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Share on Social Networks: